Clapper, E.;                     Wang, S.;                     Raninga, P.V.;                     Di Trapani, G.;                     Tonissen, K.F.    
        Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants 2020, 9, 207.
    https://doi.org/10.3390/antiox9030207
    AMA Style
    
                                Clapper E,                                 Wang S,                                 Raninga PV,                                 Di Trapani G,                                 Tonissen KF.        
                Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants. 2020; 9(3):207.
        https://doi.org/10.3390/antiox9030207
    
    Chicago/Turabian Style
    
                                Clapper, Erin,                                 Sicong Wang,                                 Prahlad V. Raninga,                                 Giovanna Di Trapani,                                 and Kathryn F. Tonissen.        
                2020. "Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment" Antioxidants 9, no. 3: 207.
        https://doi.org/10.3390/antiox9030207
    
    APA Style
    
                                Clapper, E.,                                 Wang, S.,                                 Raninga, P. V.,                                 Di Trapani, G.,                                 & Tonissen, K. F.        
        
        (2020). Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment. Antioxidants, 9(3), 207.
        https://doi.org/10.3390/antiox9030207